Eletrocardiographic Monitoring in COPD Patients Receiving Tiotropium
- 1 January 2004
- journal article
- research article
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 1 (2) , 181-190
- https://doi.org/10.1081/copd-120039560
Abstract
Tiotropium is a once‐daily, inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease that acts as a prolonged antagonist of the M3‐receptor. To ascertain whether electroph...Keywords
This publication has 30 references indexed in Scilit:
- Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax, 2003
- Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patientsAnnals of Allergy, Asthma & Immunology, 2001
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999
- Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patientsThorax, 1997
- Abnormalities of pulmonary function in patients with congestive heart failure, and reversal with ipratropium bromideThe American Journal of Cardiology, 1994
- Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failureEuropean Heart Journal, 1993
- The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisationPostgraduate Medical Journal, 1990
- Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.Thorax, 1989
- Influence of the autonomic nervous system on the Q-T interval in manThe American Journal of Cardiology, 1982
- Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei HerzkrankenActa Medica Scandinavica, 1920